Dr. Basil Michael Kahwash, MD

Dr. Kahwash practices at Mount Carmel Heart and Vascular Specialists- Westerville in Westerville, Ohio.

Dr. Kahwash's NPI, 1568843191, was assigned on June 9, 2015. Dr. Kahwash graduated from University of Toledo College of Medicine in 2015. Dr. Kahwash holds Ohio license 35.137143.

Dr. Kahwash's primary practice is Mount Carmel Heart and Vascular Specialists- Westerville, at 477 Cooper Rd, Westerville, OH 43081 in Franklin County. The practice phone is (614) 459-7676.

Dr. Kahwash's primary practice is Mount Carmel Heart and Vascular Specialists- Westerville in Westerville, Ohio. Dr. Kahwash is also affiliated with Mount Carmel East. The medical group on file is Ohio ENT & Allergy Physicians. Dmand AI also links Dr. Kahwash to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kahwash practices, 2 sites in all. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Kahwash's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dmand AI has Dr. Kahwash's licenses on file in 2 states: Ohio and Tennessee.

CMS data shows 3,999 Medicare services from Dr. Kahwash across 10 procedure codes in 2024, for 193 Medicare patients. Medicare paid $24,191 for them. Every service was in an office.

CMS counts 193 Medicare patients who saw Dr. Kahwash in 2024. The largest group is 65 to 74, with 115 patients. 70% of them have high cholesterol, and 67% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.27, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kahwash's median patient age at 41, with 61% women.

In 2024, Dr. Kahwash wrote 430 Medicare Part D claims for 121 patients. 48% of them were for generic drugs. CMS names the drug for 316 of them, across 16 drugs with 11 or more claims each, at $157,060 in total drug cost. In 2023, CMS named 149 claims across 8 drugs.

Dr. Kahwash accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 20 papers to Dr. Kahwash, published from 2013 to 2025. 2020 was the busiest year, with 3. The most frequent topics are Asthma, Exercise and COVID-19. Dr. Kahwash has published most often in J Allergy Clin Immunol Pract. Dr. Kahwash's most frequent co-authors are Sharmilee M. Nyenhuis, MD, Princess Uzoamaka Ogbogu, MD and Elizabeth Jane Phillips, MD.

CMS Open Payments shows 360 general payments to Dr. Kahwash from 29 drug and device companies from 2017 to 2025. Speaker and faculty fees make up the largest share, 56% of the total. AstraZeneca Pharmaceuticals LP paid the most, $27,273.

Dr. Kahwash graduated from University of Toledo College of Medicine in 2015.